Health Care & Life Sciences » Pharmaceuticals | High Tech Pharm Co. Ltd.

High Tech Pharm Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
39,346
43,339
32,879
10,074
3,007
Total Accounts Receivable
18,432
17,963
13,127
19,388
19,307
Inventories
8,753
7,773
10,223
10,239
8,170
Other Current Assets
832
1,908
1,335
1,793
681
Total Current Assets
67,363
70,983
57,563
41,494
31,165
Net Property, Plant & Equipment
23,737
32,202
50,525
72,782
83,440
Total Investments and Advances
4,423
3,387
3,311
3,425
3,527
Other Assets
45
23
31
497
541
Total Assets
95,568
106,595
111,430
118,310
119,098
ST Debt & Current Portion LT Debt
-
2,616
-
-
702
Accounts Payable
6,787
7,560
10,544
13,730
13,348
Income Tax Payable
1,694
590
1,136
580
96
Other Current Liabilities
1,076
2,468
1,644
1,582
2,133
Total Current Liabilities
9,557
13,233
13,324
15,893
16,279
Long-Term Debt
-
624
648
674
-
Provision for Risks & Charges
142
356
105
439
357
Deferred Taxes
9
286
64
111
425
Other Liabilities
32
32
32
32
32
Total Liabilities
9,740
14,531
14,173
17,038
16,667
Common Equity (Total)
85,828
92,064
97,205
101,178
102,194
Total Shareholders' Equity
85,828
92,064
97,205
101,178
102,194
Total Equity
85,828
92,064
97,205
101,178
102,194
Liabilities & Shareholders' Equity
95,568
106,595
111,430
118,310
119,098
Non-Equity Reserves
-
-
52
94
237

About High Tech Pharm Co.

View Profile
Address
280 Sinnae-ro
Eumseong-gun NC 27663
Korea, Republic Of
Employees -
Website http://www.htpharm.com
Updated 09/14/2018
High Tech Pharm Co., Ltd. engages in the manufacture and distribution of raw materials for injectable antibiotic products. Its products include imipenem, cilastatin sodium, blended imipenem-cilastatin sterile, meropenem, panipenem, and faropenem. The company was founded on September 1, 1998 and is headquartered in Eumseong, South Korea.